- Home
- ATRA vs CURR Comparison
ATRA vs CURR Comparison
Compare ATRA & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRA | CURR |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.4M | 123.3M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATRA | CURR |
|---|---|---|
| Price | $4.55 | $1.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | $3.50 |
| AVG Volume (30 Days) | ★ 610.3K | 227.6K |
| Earning Date | 03-06-2026 | 11-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | ★ $151,930,000.00 | $40,227,053.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.56 |
| P/E Ratio | $2.31 | ★ N/A |
| Revenue Growth | ★ 51.27 | N/A |
| 52 Week Low | $4.25 | $0.33 |
| 52 Week High | $19.15 | $4.68 |
Technical Indicators
Market Signals| Indicator | ATRA | CURR |
|---|---|---|
| Relative Strength Index (RSI) | 23.81 | 33.28 |
| Support Level | $4.25 | $1.56 |
| Resistance Level | $5.19 | $1.77 |
| Average True Range (ATR) | 1.63 | 0.16 |
| MACD | -1.54 | -0.01 |
| Stochastic Oscillator | 2.07 | 3.45 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.